Literature DB >> 3541120

Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS.

J Mills.   

Abstract

Pneumocystis carinii and Toxoplasma gondii are the commonest protozoans causing infections in patients with acquired immunodeficiency syndrome (AIDS). P. carinii is almost exclusively a pulmonary pathogen and caused the commonest serious infection experienced by AIDS patients. The clinical findings are those of progressive pneumonia. Diagnosis requires microscopic examination of lower respiratory secretions or lung tissue. Pentamidine or combinations of trimethoprim and sulfamethoxazole are equally effective (85% recovery), but about one-half of patients thus treated experience severe toxicity. T. gondii infections occur primarily in the brain; patients present with focal seizures or neurologic deficit and have focal abnormalities as assessed by computed tomography. Serologic tests for toxoplasmosis are rarely diagnostic in AIDS patients, and most patients are treated empirically with a combination of pyrimethamine and sulfonamide. Less invasive diagnostic tests and better chemotherapeutic agents are required for both pneumocystosis and toxoplasmosis.

Entities:  

Mesh:

Year:  1986        PMID: 3541120     DOI: 10.1093/clinids/8.6.1001

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  39 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii.

Authors:  L D Sibley; A J LeBlanc; E R Pfefferkorn; J C Boothroyd
Journal:  Genetics       Date:  1992-12       Impact factor: 4.562

3.  Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS.

Authors:  M J Gill; R Read
Journal:  Can J Infect Dis       Date:  1991

4.  Rapid microscopy technique for detection of Pneumocystis carinii in fresh clinical specimens.

Authors:  G Chichino; A Bruno; C Cevini; S Gatti; M Scaglia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

5.  Isolation of Pneumocystis carinii cysts by flow cytometry.

Authors:  J A De Stefano; R G Sleight; G F Babcock; R M Sramkoski; P D Walzer
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

6.  In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii.

Authors:  F G Araujo; J Huskinson-Mark; W E Gutteridge; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.

Authors:  C H Lee; J J Lu; M S Bartlett; M M Durkin; T H Liu; J Wang; B Jiang; J W Smith
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Evidence for N-linked glycosylation in Toxoplasma gondii.

Authors:  M Odenthal-Schnittler; S Tomavo; D Becker; J F Dubremetz; R T Schwarz
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology.

Authors:  J B Roths; J D Marshall; R D Allen; G A Carlson; C L Sidman
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

10.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.